Adverse Event Reporting
| VAERS ID | 987105 |
|---|---|
| Gender | Male |
| Age | 68 |
| StateCode | OK |
| Pharmaceutical Company | MODERNA |
| Lot Number | 025J202A |
| Number of vaccinations | 1 |
| Vaccinated | 2021-01-09 |
| Onset | 2021-01-19 |
| Condition | Hospitalized Permanent Disability |
Symptoms
- White blood cell count normal
- Muscular weakness
- Blood glucose increased
- Gait disturbance
- Magnetic resonance imaging spinal abnormal
- Guillain-Barre syndrome
- CSF protein increased
- Lumbar puncture abnormal
- Plasmapheresis
- Central venous catheterisation
- Spinal cord lipoma
Current Illness
Not applicable
Preexisting Conditions
Diabetes
Other Medications
1) ASA 81 mg a day 2) Jardiance 25 mg daily 3)Gabapentin 300 mg TID 4) Insulin 60 units at bedtime 5) Lisinopril 10 mg daily 6) Pravastatin 80 mg daily 7) Janumet XR 50-500 two pills daily
Previous Vaccinations
Allergies
shellfish
Laboratory Data
1) Lumbar puncture with elevated CSF protein count of 110 with normal white blood cell count and minimally elevated glucose count 2) MRI of the lumbar spine with lumbar lipoma but no acute process being identified 3) Central line placement and the start of a 5 course plasmapheresis treatment
Write-up
The patient noted weakness starting in the legs on January the 19th, 10 days after receiving the first dose of the vaccine.
The weakness progressed to the point that he was able to ambulate only with assistance.
He was seen in my neurology clinic on January 28th and his evaluation suggested an ascending, painless weakness of the legs with rapidly progressive symptoms.
He was admitted to Hospital on the same day.
His evaluation is consistent with Guillain Barre Syndrome and he has been started on plasmapheresis to treat the condition.